BioLineRx (BLRX) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

BLRX is expected to report earnings to fall ∞% to -9 cents per share on November 13

Q3'24

Est.

$-0.09

Q2'24

Beat

by $0.14

Q1'24

Beat

by $0.16

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.20

The last earnings report on August 15 showed earnings per share of 0 cents, beating the estimate of -14 cents. With 145.92K shares outstanding, the current market capitalization sits at 53.57M.

View a ticker or compare two or three

Compare

BLRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BLRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical development company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

2 HaMaâ€™ayan Street

Phone

+972 86429100

Employees

Web

https://www.biolinerx.com